Oragenics (OGEN) EBITDA Margin (2010 - 2023)
Oragenics' (OGEN) quarterly EBITDA Margin came in at 28053.12% in Q3 2023, down 2351314.0% YoY from N/an in Q3 2022, and down 18.76% on a QoQ basis from 23621.65% in Q2 2023.
Oragenics (OGEN) EBITDA Margin (2010 - 2023) Analysis & Trends
Oragenics (OGEN) has 7 years of EBITDA Margin data on file, last reported at 28053.12% in Q3 2023.
- Quarterly EBITDA Margin fell 2351314.0% year-over-year to 28053.12% in Q3 2023, while the trailing twelve-month figure through Dec 2023 was 55519.89% (down 4455565.0% YoY) and the FY2023 annual result came in at 55519.89%, down 4455527.0% from the prior year.
- EBITDA Margin slipped to 28053.12% in Q3 2023, from 23621.65% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 4539.98% in Q3 2022 to a low of 30565.05% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -28,053.12% |
| Jun 30, 2023 | -23,621.65% |
| Mar 31, 2023 | -17,063.06% |
| Sep 30, 2022 | -4,539.98% |
| Jun 30, 2022 | -11,860.30% |
| Mar 31, 2022 | -30,565.05% |
| Dec 31, 2014 | -557.89% |
| Sep 30, 2014 | -514.82% |
| Jun 30, 2014 | -626.34% |
| Mar 31, 2014 | -768.17% |
| Dec 31, 2013 | -706.87% |
| Sep 30, 2013 | -3,680.51% |
| Jun 30, 2013 | -1,237.72% |
| Mar 31, 2013 | -984.16% |
| Dec 31, 2012 | -461.74% |
| Sep 30, 2012 | -793.41% |
| Jun 30, 2012 | -2,678.83% |
| Mar 31, 2012 | -388.64% |
| Dec 31, 2011 | -457.78% |
| Sep 30, 2011 | -488.40% |